Oncolytics Biotech, Inc.

It’s only half-way through the month of July but Chinese bioventures have already raised new funds at a record-setting pace to accelerate clinical development of their new drugs and cell therapies. No

AstraZeneca PLC and immunotherapy specialist Transgene SA are to work together to develop armed oncolytic vaccinia virus candidates. The companies announced on 2 May that they have signed a deal to

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Amgen, M